CYPH — Cypherpunk Technologies Share News
0.000.00%
- $321.14m
- $313.51m
Cypherpunk Technologies swings to Q2 profit on Zcash gains
Cypherpunk Technologies Inc expected to post a loss of 3 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies
Cypherpunk Technologies slumps after crypto token Zcash plunges
Cypherpunk Technologies Q1 net loss widens
Brief: Cypherpunk Reports Full Year 2025 Financial Results
Brief: Cypherpunk Technologies Inc - Buys 56,418.09 Zec For $29 Million - SEC Filing
Brief: Josh Swihart, ECC CEO, Joins Cypherpunk As Strategic Advisor
Cypherpunk Technologies' Q3 net loss narrows
Brief: Leap Therapeutics Rebrands as Cypherpunk
Brief: Leap Therapeutics Reports Second Quarter Financial Results
Leap Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-DoorDash, Accenture, KB Home
U.S. STOCKS ON THE MOVE-Fiserv, Eli Lilly, Nuclear stocks
Leap Therapeutics rises after co to cut 75% staff, cancer drug succeeds in mid-stage trial
Brief: Leap Therapeutics Reports Updated Clinical Data From Sirexatamab Colorectal Cancer Study